|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.560 BRL | -3.64% |
|
-3.14% | +11.20% |
| Jan. 29 | SAP's 2026 cloud forecasts disappoint, shares endure biggest daily loss since 2020 | RE |
| Jan. 20 | Brazil's Dexco signs contract to sell standing timber | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.72 | 7.38 | 3.81 | 0.96 | 1.66 | |||||
Return on Total Capital | 4.81 | 9.8 | 4.94 | 1.2 | 2.03 | |||||
Return On Equity % | 8.97 | 31.6 | 13.08 | 13 | 2.54 | |||||
Return on Common Equity | 8.97 | 31.6 | 13.03 | 12.86 | 2.58 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 29.53 | 33.3 | 27.44 | 23.13 | 24.9 | |||||
SG&A Margin | 17.64 | 15.04 | 16.96 | 19.34 | 18.77 | |||||
EBITDA Margin % | 21.03 | 26.12 | 19.66 | 17.73 | 19.45 | |||||
EBITA Margin % | 11.7 | 18.3 | 10.72 | 3.82 | 6.05 | |||||
EBIT Margin % | 11.25 | 18 | 10.43 | 3.48 | 5.81 | |||||
Income From Continuing Operations Margin % | 7.72 | 21.12 | 9.01 | 10.99 | 2.12 | |||||
Net Income Margin % | 7.72 | 21.12 | 8.91 | 10.69 | 2.09 | |||||
Net Avail. For Common Margin % | 7.72 | 21.12 | 8.91 | 10.69 | 2.09 | |||||
Normalized Net Income Margin | 4.67 | 9.4 | 2.76 | -1.79 | -1.44 | |||||
Levered Free Cash Flow Margin | 13.58 | 7.33 | -6.66 | 0.65 | -6.94 | |||||
Unlevered Free Cash Flow Margin | 15.15 | 8.75 | -1.69 | 7.14 | -1.05 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.53 | 0.66 | 0.58 | 0.44 | 0.46 | |||||
Fixed Assets Turnover | 1.1 | 1.59 | 1.45 | 1.06 | 1.06 | |||||
Receivables Turnover (Average Receivables) | 4.95 | 6.12 | 5.94 | 5.71 | 6.92 | |||||
Inventory Turnover (Average Inventory) | 4.66 | 4.62 | 4.05 | 3.77 | 3.88 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.75 | 1.38 | 1.58 | 1.6 | 1.39 | |||||
Quick Ratio | 1.34 | 0.94 | 1.07 | 1.19 | 0.93 | |||||
Operating Cash Flow to Current Liabilities | 0.63 | 0.51 | 0.24 | 0.37 | 0.35 | |||||
Days Sales Outstanding (Average Receivables) | 73.91 | 59.63 | 61.41 | 63.91 | 52.9 | |||||
Days Outstanding Inventory (Average Inventory) | 78.53 | 78.96 | 90.03 | 96.73 | 94.21 | |||||
Average Days Payable Outstanding | 76.36 | 86.47 | 85.36 | 81.69 | 72.52 | |||||
Cash Conversion Cycle (Average Days) | 76.07 | 52.12 | 66.07 | 78.95 | 74.59 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 68.77 | 74.45 | 107.61 | 120.73 | 107.14 | |||||
Total Debt / Total Capital | 40.75 | 42.68 | 51.83 | 54.7 | 51.72 | |||||
LT Debt/Equity | 57.25 | 59.15 | 91.68 | 101.07 | 87.09 | |||||
Long-Term Debt / Total Capital | 33.92 | 33.9 | 44.16 | 45.79 | 42.04 | |||||
Total Liabilities / Total Assets | 54.88 | 57.27 | 61.85 | 63.61 | 60.34 | |||||
EBIT / Interest Expense | 4.49 | 7.93 | 1.31 | 0.34 | 0.62 | |||||
EBITDA / Interest Expense | 8.63 | 11.7 | 2.53 | 1.8 | 2.16 | |||||
(EBITDA - Capex) / Interest Expense | 5.68 | 7.4 | 0.84 | 0.27 | 0.45 | |||||
Total Debt / EBITDA | 2.81 | 1.97 | 3.74 | 5.71 | 4.59 | |||||
Net Debt / EBITDA | 1.45 | 1.31 | 2.71 | 3.69 | 3.42 | |||||
Total Debt / (EBITDA - Capex) | 4.27 | 3.11 | 11.35 | 37.62 | 22.08 | |||||
Net Debt / (EBITDA - Capex) | 2.2 | 2.07 | 8.21 | 24.31 | 16.44 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 17.32 | 38.96 | 3.87 | -13 | 11.53 | |||||
Gross Profit, 1 Yr. Growth % | 43.11 | 56.71 | -14.41 | -26.65 | 20.04 | |||||
EBITDA, 1 Yr. Growth % | 33.07 | 72.1 | -21.78 | -21.48 | 22.32 | |||||
EBITA, 1 Yr. Growth % | 146.73 | 117.08 | -39.1 | -68.99 | 76.75 | |||||
EBIT, 1 Yr. Growth % | 161.67 | 121.43 | -39.76 | -70.92 | 86.05 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 11.89 | 280.12 | -55.67 | 6.06 | -78.51 | |||||
Net Income, 1 Yr. Growth % | 11.9 | 280.2 | -56.19 | 4.46 | -78.16 | |||||
Normalized Net Income, 1 Yr. Growth % | 485.79 | 178.41 | -70.23 | -156.49 | 1.07K | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 12.12 | 316.87 | -59.02 | 5.64 | -78.18 | |||||
Accounts Receivable, 1 Yr. Growth % | 9.17 | 15.4 | -0.34 | -18.59 | 5.15 | |||||
Inventory, 1 Yr. Growth % | 8.37 | 54.99 | 11.96 | -12.55 | 6.5 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -11.86 | 5.41 | 22.12 | 16.66 | 10.11 | |||||
Total Assets, 1 Yr. Growth % | 7.32 | 16.71 | 16.43 | 14.69 | 0.96 | |||||
Tangible Book Value, 1 Yr. Growth % | 5.82 | 11.83 | 0.23 | 10.92 | 10.88 | |||||
Common Equity, 1 Yr. Growth % | 5.19 | 10.54 | 2.42 | 9.05 | 8.95 | |||||
Cash From Operations, 1 Yr. Growth % | 36.02 | 13.31 | -53.54 | 69.59 | -4.61 | |||||
Capital Expenditures, 1 Yr. Growth % | 0.93 | 84.06 | 43.95 | 1.81 | 13.7 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 98.78 | -24.95 | -194.87 | -108.5 | 515.06 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 66.74 | -19.68 | -120.1 | -460.3 | -122.35 | |||||
Dividend Per Share, 1 Yr. Growth % | -15.79 | 307.33 | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 8.99 | 27.68 | 20.14 | -4.94 | -1.5 | |||||
Gross Profit, 2 Yr. CAGR % | 22.85 | 52.61 | 15.87 | -21.05 | -5.04 | |||||
EBITDA, 2 Yr. CAGR % | 9.35 | 31.56 | 15.91 | -28.24 | -1.24 | |||||
EBITA, 2 Yr. CAGR % | 64.01 | 70.65 | 21 | -60.76 | -20.93 | |||||
EBIT, 2 Yr. CAGR % | 70.36 | 69.24 | 19.35 | -62.52 | -22.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 2.54 | 106.24 | 29.8 | -31.44 | -52.25 | |||||
Net Income, 2 Yr. CAGR % | 2.54 | 106.26 | 29.06 | -32.35 | -52.24 | |||||
Normalized Net Income, 2 Yr. CAGR % | 157.92 | 86.64 | -5.14 | -66.26 | -21.15 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 2.6 | 116.19 | 30.7 | -37.27 | -51.99 | |||||
Accounts Receivable, 2 Yr. CAGR % | 1.03 | 12.24 | 7.24 | -9.92 | -7.48 | |||||
Inventory, 2 Yr. CAGR % | 7.7 | 29.6 | 31.73 | -1.05 | 1.16 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 1.96 | -3.61 | 13.46 | 19.36 | 12.29 | |||||
Total Assets, 2 Yr. CAGR % | 10.12 | 11.92 | 16.57 | 15.56 | 7.76 | |||||
Tangible Book Value, 2 Yr. CAGR % | 2.86 | 8.78 | 5.87 | 5.44 | 10.9 | |||||
Common Equity, 2 Yr. CAGR % | 5.8 | 7.83 | 6.4 | 5.68 | 9 | |||||
Cash From Operations, 2 Yr. CAGR % | 98.44 | 24.14 | -27.45 | -11.24 | 27.19 | |||||
Capital Expenditures, 2 Yr. CAGR % | 2.12 | 36.3 | 62.78 | 21.06 | 7.59 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 45.18 | 6.35 | -9.56 | -74.44 | -14.54 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 26.45 | 1.48 | -59.2 | -24.77 | -35.98 | |||||
Dividend Per Share, 2 Yr. CAGR % | -37.01 | 85.21 | - | -54.9 | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 13.79 | 18.18 | 19.19 | 7.89 | 0.26 | |||||
Gross Profit, 3 Yr. CAGR % | 23.18 | 33.23 | 25.86 | -0.51 | -9.22 | |||||
EBITDA, 3 Yr. CAGR % | 22.21 | 27.33 | 10.6 | 1.78 | -14.28 | |||||
EBITA, 3 Yr. CAGR % | 67.61 | 80.16 | 21 | -23.16 | -35.2 | |||||
EBIT, 3 Yr. CAGR % | 77.28 | 86.14 | 19.9 | -25.48 | -36.07 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 34.88 | 58.69 | 23.54 | 21.35 | -53.42 | |||||
Net Income, 3 Yr. CAGR % | 34.9 | 58.71 | 23.06 | 20.28 | -53.6 | |||||
Normalized Net Income, 3 Yr. CAGR % | 66.42 | 165.05 | 2.1 | -20.25 | -53.27 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 35.02 | 63.72 | 24.19 | 21.75 | -55.88 | |||||
Accounts Receivable, 3 Yr. CAGR % | 8.58 | 5.61 | 7.88 | -2.17 | -5.16 | |||||
Inventory, 3 Yr. CAGR % | 6.75 | 21.59 | 23.43 | 14.92 | 4.64 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -1.27 | 3.1 | 4.3 | 14.51 | 15.48 | |||||
Total Assets, 3 Yr. CAGR % | 6.7 | 12.28 | 13.4 | 15.94 | 10.58 | |||||
Tangible Book Value, 3 Yr. CAGR % | 3.15 | 5.77 | 5.85 | 7.53 | 7.22 | |||||
Common Equity, 3 Yr. CAGR % | 3.23 | 7.36 | 6 | 7.28 | 6.76 | |||||
Cash From Operations, 3 Yr. CAGR % | 55.02 | 64.63 | -10.54 | -3.71 | -9.08 | |||||
Capital Expenditures, 3 Yr. CAGR % | 6.67 | 24.28 | 38.8 | 39.21 | 18.56 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 51.01 | 16.5 | 2.21 | -58.81 | -8.23 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 30.94 | 8.68 | -40.93 | -15.05 | -54.76 | |||||
Dividend Per Share, 3 Yr. CAGR % | 52.75 | 17.35 | - | -6.08 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.21 | 15.88 | 16.29 | 8.33 | 10.44 | |||||
Gross Profit, 5 Yr. CAGR % | 9.13 | 26.16 | 20.18 | 8.23 | 11.91 | |||||
EBITDA, 5 Yr. CAGR % | 10.17 | 26.55 | 19.76 | 4.84 | 5.37 | |||||
EBITA, 5 Yr. CAGR % | 26.99 | 69.73 | 44.16 | 1.96 | -0.6 | |||||
EBIT, 5 Yr. CAGR % | 29.65 | 79.59 | 49.43 | 2.43 | -1.4 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 18.81 | 131.01 | 32.83 | 13.44 | -15.54 | |||||
Net Income, 5 Yr. CAGR % | 19.85 | 135.85 | 32.53 | 12.84 | -15.72 | |||||
Normalized Net Income, 5 Yr. CAGR % | 53.4 | 40.46 | 31.56 | 26.25 | -11.66 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 19.5 | 140.06 | 33.28 | 13.69 | -15.08 | |||||
Accounts Receivable, 5 Yr. CAGR % | 7.23 | 11.36 | 8.04 | -0.9 | 1.45 | |||||
Inventory, 5 Yr. CAGR % | 3.03 | 12.3 | 16.12 | 11.97 | 13.99 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -0.81 | 0.63 | 4.38 | 9.32 | 7.42 | |||||
Total Assets, 5 Yr. CAGR % | 5 | 7.52 | 10.54 | 13.58 | 11.11 | |||||
Tangible Book Value, 5 Yr. CAGR % | 2.3 | 4.31 | 4.23 | 5.64 | 7.84 | |||||
Common Equity, 5 Yr. CAGR % | 2.73 | 4.64 | 4.49 | 6.68 | 7.19 | |||||
Cash From Operations, 5 Yr. CAGR % | 21.29 | 30.54 | 14.42 | 28.59 | 2.98 | |||||
Capital Expenditures, 5 Yr. CAGR % | -1 | 16.72 | 26.32 | 22.98 | 25.36 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 66.46 | 33.87 | 19.52 | -33.76 | 1.54 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 20.83 | 85.5 | -18.45 | -1.1 | -34.11 | |||||
Dividend Per Share, 5 Yr. CAGR % | 0.24 | 170.71 | - | -19.95 | - |
- Stock Market
- Equities
- DXCO3 Stock
- Financials Dexco S.A.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















